[HTML] springer.comFull View

[HTML][HTML] Automated classification of urine biomarkers to diagnose pancreatic cancer using 1-D convolutional neural networks

ME Karar, N El-Fishawy, M Radad - Journal of Biological Engineering, 2023 - Springer
Abstract Background Early diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC) is the
main key to surviving cancer patients. Urine proteomic biomarkers which are creatinine …
被引用次数：10 相关文章

Automated classification of urine biomarkers to diagnose pancreatic cancer using 1-D convolutional neural networks.

ME Karar, N El-Fishawy… - Journal of Biological …, 2023 - search.ebscohost.com
Abstract Background: Early diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC) is the
main key to surviving cancer patients. Urine proteomic biomarkers which are creatinine …

Automated classification of urine biomarkers to diagnose pancreatic cancer using 1-D convolutional neural networks.

ME Karar, N El-Fishawy, M Radad - Journal of Biological …, 2023 - europepmc.org
Background Early diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC) is the main key
to surviving cancer patients. Urine proteomic biomarkers which are creatinine, LYVE1 …
[HTML] nih.gov

[HTML][HTML] Automated classification of urine biomarkers to diagnose pancreatic cancer using 1-D convolutional neural networks

ME Karar, N El-Fishawy, M Radad - Journal of Biological …, 2023 - ncbi.nlm.nih.gov
Background Early diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC) is the main key
to surviving cancer patients. Urine proteomic biomarkers which are creatinine, LYVE1 …

Automated classification of urine biomarkers to diagnose pancreatic cancer using 1-D convolutional neural networks

ME Karar, N El-Fishawy… - Journal of biological …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Early diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC) is the main key
to surviving cancer patients. Urine proteomic biomarkers which are creatinine, LYVE1 …
[HTML] biomedcentral.com

[HTML][HTML] Automated classification of urine biomarkers to diagnose pancreatic cancer using 1-D convolutional neural networks

ME Karar, N El-Fishawy… - Journal of Biological …, 2023 - jbioleng.biomedcentral.com
Early diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC) is the main key to surviving
cancer patients. Urine proteomic biomarkers which are creatinine, LYVE1, REG1B, and …

Automated classification of urine biomarkers to diagnose pancreatic cancer using 1-D convolutional neural networks

ME Karar, N El-Fishawy… - Journal of Biological …, 2023 - search.proquest.com
Background Early diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC) is the main key
to surviving cancer patients. Urine proteomic biomarkers which are creatinine, LYVE1 …

[引用][C] Automated classification of urine biomarkers to diagnose pancreatic cancer using 1-D convolutional neural networks

ME Karar, N El‑Fishawy, M Radad - 2023 - europepmc.org
Abstract Background Early diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC) is the
main key to surviving cancer patients. Urine proteomic biomarkers which are creatinine …
[PDF] biomedcentral.com

[PDF][PDF] Automated classification of urine biomarkers to diagnose pancreatic cancer using 1-D convolutional neural networks

ME Karar, N El‑Fishawy, M Radad - 2023 - jbioleng.biomedcentral.com
Abstract Background Early diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC) is the
main key to surviving cancer patients. Urine proteomic biomarkers which are creatinine …